Global Neurotech devices Market

Neurotech devices Comprehensive Study by Type (Neuroprosthetics, Neural stimulators, Neurorehabilitation, Neurosensing, Others), Application (Hospitals, Clinics, Diagnostic Centers), Disease (Parkinson's Disease, Cerebral Palsy, Cognitive Disorders, Epilepsy, Incontinence, Migraine, Hearing Conditions, Chronic Pain, Spinal Cord Injury, Stroke, Traumatic Brain Injury), End Use (Diagnostics, Therapeutics) Players and Region - Global Market Outlook to 2026

Neurotech devices Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Neurotech devices Market Overview:
Recent advancements in neuroscience have opened the way for cutting-edge applications that cognitively augment and improve humans in a variety of settings. Neurotechnologies are a branch of science and engineering in which the nervous system is linked to technological devices. Technical aids such as reading lenses, hearing aids, and walking frames have become commonplace in ageing communities. Medical assistive technologies have evolved into little aids, and their use is hardly debated in the majority of situations. Wearable neurotechnologies and brain-computer interfaces are now being used to measure real-time neuronal and physiologic impulses from the human body, and they have enormous potential for medical diagnostics, prevention, and action.

Growth Drivers
  • Prevalence of Parkinson's Disease Cases
  • Rising Geriatric Population
  • Emergence of Advance and Effective Techniques

Market Trends
  • Growing Investments in Healthcare Infrastructure

Roadblocks
  • Lack of Trained Professionals
  • High-Cost Expense

Opportunities
  • Low Penetration in Emerging Economies Particularly in Asian Region

Challenges
  • Fierce Competitive Pressure
  • Regulatory Approval


Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Abbott Laboratories (United States), Advanced Bionics Corp (United States), Stryker Corporation (United States), Axonics Modulation Technologies Inc. (United States), Boston Scientific Corp (United States), Cogentix Medical (United States), Cleveland Medical Devices (United States), LivaNova (United Kingdom), Medtronic (United States) and Natus Medical Incorporated (United States). Additionally, following companies can also be profiled that are part of our coverage like Neuronetics (United States), EndoStim Inc. (United States), Flow Neuroscience AB (Sweden), NeuroSigma (United States), Restorative Therapies Inc. (United States) and Zynex Medical Inc. (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Neurotech devices market by 2026. Considering Market by Disease, the sub-segment i.e. Parkinson's Disease will boost the Neurotech devices market. Considering Market by End Use, the sub-segment i.e. Diagnostics will boost the Neurotech devices market.

Latest Market Insights:


On 4th February, 2021 - Imperial College Fund Innovation Fund (ICIF) Invests £205K In Parkinson's Treatment Device, called “Charco Neurotech”. Charco Neurotech is a Non-Invasive Vibrating Device to Manage Parkinson’s Symptoms.

United States Food and Drug Administration “Neurological Devices” – USDA is the Key Regulatory Authority Responsible for Inspection, Classification and Labelling of the Neurological Devices Based on its Quality Standards. Any New Entrant or Manufacturer is Required to have Regulatory Approval from FDA for the Sale Across US.

What Can be Explored with the Neurotech devices Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Neurotech devices Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Neurotech devices
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Neurotech devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Neurotech devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Neurotech devices Manufactures, New Entrants and Investors, Neurotech devices Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Neuroprosthetics
  • Neural stimulators
  • Neurorehabilitation
  • Neurosensing
  • Others
By Application
  • Hospitals
  • Clinics
  • Diagnostic Centers
By Disease
  • Parkinson's Disease
  • Cerebral Palsy
  • Cognitive Disorders
  • Epilepsy, Incontinence
  • Migraine
  • Hearing Conditions
  • Chronic Pain
  • Spinal Cord Injury
  • Stroke
  • Traumatic Brain Injury

By End Use
  • Diagnostics
  • Therapeutics

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Prevalence of Parkinson's Disease Cases
      • 3.2.2. Rising Geriatric Population
      • 3.2.3. Emergence of Advance and Effective Techniques
    • 3.3. Market Challenges
      • 3.3.1. Fierce Competitive Pressure
      • 3.3.2. Regulatory Approval
    • 3.4. Market Trends
      • 3.4.1. Growing Investments in Healthcare Infrastructure
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Neurotech devices, by Type, Application, Disease, End Use and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Neurotech devices (Value)
      • 5.2.1. Global Neurotech devices by: Type (Value)
        • 5.2.1.1. Neuroprosthetics
        • 5.2.1.2. Neural stimulators
        • 5.2.1.3. Neurorehabilitation
        • 5.2.1.4. Neurosensing
        • 5.2.1.5. Others
      • 5.2.2. Global Neurotech devices by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Diagnostic Centers
      • 5.2.3. Global Neurotech devices by: Disease (Value)
        • 5.2.3.1. Parkinson's Disease
        • 5.2.3.2. Cerebral Palsy
        • 5.2.3.3. Cognitive Disorders
        • 5.2.3.4. Epilepsy, Incontinence
        • 5.2.3.5. Migraine
        • 5.2.3.6. Hearing Conditions
        • 5.2.3.7. Chronic Pain
        • 5.2.3.8. Spinal Cord Injury
        • 5.2.3.9. Stroke
        • 5.2.3.10. Traumatic Brain Injury
      • 5.2.4. Global Neurotech devices by: End Use (Value)
        • 5.2.4.1. Diagnostics
        • 5.2.4.2. Therapeutics
      • 5.2.5. Global Neurotech devices Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Neurotech devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Advanced Bionics Corp (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Stryker Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Axonics Modulation Technologies Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Boston Scientific Corp (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cogentix Medical (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cleveland Medical Devices (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. LivaNova (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Medtronic (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Natus Medical Incorporated (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Neurotech devices Sale, by Type, Application, Disease, End Use and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Neurotech devices (Value)
      • 7.2.1. Global Neurotech devices by: Type (Value)
        • 7.2.1.1. Neuroprosthetics
        • 7.2.1.2. Neural stimulators
        • 7.2.1.3. Neurorehabilitation
        • 7.2.1.4. Neurosensing
        • 7.2.1.5. Others
      • 7.2.2. Global Neurotech devices by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Diagnostic Centers
      • 7.2.3. Global Neurotech devices by: Disease (Value)
        • 7.2.3.1. Parkinson's Disease
        • 7.2.3.2. Cerebral Palsy
        • 7.2.3.3. Cognitive Disorders
        • 7.2.3.4. Epilepsy, Incontinence
        • 7.2.3.5. Migraine
        • 7.2.3.6. Hearing Conditions
        • 7.2.3.7. Chronic Pain
        • 7.2.3.8. Spinal Cord Injury
        • 7.2.3.9. Stroke
        • 7.2.3.10. Traumatic Brain Injury
      • 7.2.4. Global Neurotech devices by: End Use (Value)
        • 7.2.4.1. Diagnostics
        • 7.2.4.2. Therapeutics
      • 7.2.5. Global Neurotech devices Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Neurotech devices: by Type(USD Million)
  • Table 2. Neurotech devices Neuroprosthetics , by Region USD Million (2015-2020)
  • Table 3. Neurotech devices Neural stimulators , by Region USD Million (2015-2020)
  • Table 4. Neurotech devices Neurorehabilitation , by Region USD Million (2015-2020)
  • Table 5. Neurotech devices Neurosensing , by Region USD Million (2015-2020)
  • Table 6. Neurotech devices Others , by Region USD Million (2015-2020)
  • Table 7. Neurotech devices: by Application(USD Million)
  • Table 8. Neurotech devices Hospitals , by Region USD Million (2015-2020)
  • Table 9. Neurotech devices Clinics , by Region USD Million (2015-2020)
  • Table 10. Neurotech devices Diagnostic Centers , by Region USD Million (2015-2020)
  • Table 11. Neurotech devices: by Disease(USD Million)
  • Table 12. Neurotech devices Parkinson's Disease , by Region USD Million (2015-2020)
  • Table 13. Neurotech devices Cerebral Palsy , by Region USD Million (2015-2020)
  • Table 14. Neurotech devices Cognitive Disorders , by Region USD Million (2015-2020)
  • Table 15. Neurotech devices Epilepsy, Incontinence , by Region USD Million (2015-2020)
  • Table 16. Neurotech devices Migraine , by Region USD Million (2015-2020)
  • Table 17. Neurotech devices Hearing Conditions , by Region USD Million (2015-2020)
  • Table 18. Neurotech devices Chronic Pain , by Region USD Million (2015-2020)
  • Table 19. Neurotech devices Spinal Cord Injury , by Region USD Million (2015-2020)
  • Table 20. Neurotech devices Stroke , by Region USD Million (2015-2020)
  • Table 21. Neurotech devices Traumatic Brain Injury , by Region USD Million (2015-2020)
  • Table 22. Neurotech devices: by End Use(USD Million)
  • Table 23. Neurotech devices Diagnostics , by Region USD Million (2015-2020)
  • Table 24. Neurotech devices Therapeutics , by Region USD Million (2015-2020)
  • Table 25. South America Neurotech devices, by Country USD Million (2015-2020)
  • Table 26. South America Neurotech devices, by Type USD Million (2015-2020)
  • Table 27. South America Neurotech devices, by Application USD Million (2015-2020)
  • Table 28. South America Neurotech devices, by Disease USD Million (2015-2020)
  • Table 29. South America Neurotech devices, by End Use USD Million (2015-2020)
  • Table 30. Brazil Neurotech devices, by Type USD Million (2015-2020)
  • Table 31. Brazil Neurotech devices, by Application USD Million (2015-2020)
  • Table 32. Brazil Neurotech devices, by Disease USD Million (2015-2020)
  • Table 33. Brazil Neurotech devices, by End Use USD Million (2015-2020)
  • Table 34. Argentina Neurotech devices, by Type USD Million (2015-2020)
  • Table 35. Argentina Neurotech devices, by Application USD Million (2015-2020)
  • Table 36. Argentina Neurotech devices, by Disease USD Million (2015-2020)
  • Table 37. Argentina Neurotech devices, by End Use USD Million (2015-2020)
  • Table 38. Rest of South America Neurotech devices, by Type USD Million (2015-2020)
  • Table 39. Rest of South America Neurotech devices, by Application USD Million (2015-2020)
  • Table 40. Rest of South America Neurotech devices, by Disease USD Million (2015-2020)
  • Table 41. Rest of South America Neurotech devices, by End Use USD Million (2015-2020)
  • Table 42. Asia Pacific Neurotech devices, by Country USD Million (2015-2020)
  • Table 43. Asia Pacific Neurotech devices, by Type USD Million (2015-2020)
  • Table 44. Asia Pacific Neurotech devices, by Application USD Million (2015-2020)
  • Table 45. Asia Pacific Neurotech devices, by Disease USD Million (2015-2020)
  • Table 46. Asia Pacific Neurotech devices, by End Use USD Million (2015-2020)
  • Table 47. China Neurotech devices, by Type USD Million (2015-2020)
  • Table 48. China Neurotech devices, by Application USD Million (2015-2020)
  • Table 49. China Neurotech devices, by Disease USD Million (2015-2020)
  • Table 50. China Neurotech devices, by End Use USD Million (2015-2020)
  • Table 51. Japan Neurotech devices, by Type USD Million (2015-2020)
  • Table 52. Japan Neurotech devices, by Application USD Million (2015-2020)
  • Table 53. Japan Neurotech devices, by Disease USD Million (2015-2020)
  • Table 54. Japan Neurotech devices, by End Use USD Million (2015-2020)
  • Table 55. India Neurotech devices, by Type USD Million (2015-2020)
  • Table 56. India Neurotech devices, by Application USD Million (2015-2020)
  • Table 57. India Neurotech devices, by Disease USD Million (2015-2020)
  • Table 58. India Neurotech devices, by End Use USD Million (2015-2020)
  • Table 59. South Korea Neurotech devices, by Type USD Million (2015-2020)
  • Table 60. South Korea Neurotech devices, by Application USD Million (2015-2020)
  • Table 61. South Korea Neurotech devices, by Disease USD Million (2015-2020)
  • Table 62. South Korea Neurotech devices, by End Use USD Million (2015-2020)
  • Table 63. Taiwan Neurotech devices, by Type USD Million (2015-2020)
  • Table 64. Taiwan Neurotech devices, by Application USD Million (2015-2020)
  • Table 65. Taiwan Neurotech devices, by Disease USD Million (2015-2020)
  • Table 66. Taiwan Neurotech devices, by End Use USD Million (2015-2020)
  • Table 67. Australia Neurotech devices, by Type USD Million (2015-2020)
  • Table 68. Australia Neurotech devices, by Application USD Million (2015-2020)
  • Table 69. Australia Neurotech devices, by Disease USD Million (2015-2020)
  • Table 70. Australia Neurotech devices, by End Use USD Million (2015-2020)
  • Table 71. Rest of Asia-Pacific Neurotech devices, by Type USD Million (2015-2020)
  • Table 72. Rest of Asia-Pacific Neurotech devices, by Application USD Million (2015-2020)
  • Table 73. Rest of Asia-Pacific Neurotech devices, by Disease USD Million (2015-2020)
  • Table 74. Rest of Asia-Pacific Neurotech devices, by End Use USD Million (2015-2020)
  • Table 75. Europe Neurotech devices, by Country USD Million (2015-2020)
  • Table 76. Europe Neurotech devices, by Type USD Million (2015-2020)
  • Table 77. Europe Neurotech devices, by Application USD Million (2015-2020)
  • Table 78. Europe Neurotech devices, by Disease USD Million (2015-2020)
  • Table 79. Europe Neurotech devices, by End Use USD Million (2015-2020)
  • Table 80. Germany Neurotech devices, by Type USD Million (2015-2020)
  • Table 81. Germany Neurotech devices, by Application USD Million (2015-2020)
  • Table 82. Germany Neurotech devices, by Disease USD Million (2015-2020)
  • Table 83. Germany Neurotech devices, by End Use USD Million (2015-2020)
  • Table 84. France Neurotech devices, by Type USD Million (2015-2020)
  • Table 85. France Neurotech devices, by Application USD Million (2015-2020)
  • Table 86. France Neurotech devices, by Disease USD Million (2015-2020)
  • Table 87. France Neurotech devices, by End Use USD Million (2015-2020)
  • Table 88. Italy Neurotech devices, by Type USD Million (2015-2020)
  • Table 89. Italy Neurotech devices, by Application USD Million (2015-2020)
  • Table 90. Italy Neurotech devices, by Disease USD Million (2015-2020)
  • Table 91. Italy Neurotech devices, by End Use USD Million (2015-2020)
  • Table 92. United Kingdom Neurotech devices, by Type USD Million (2015-2020)
  • Table 93. United Kingdom Neurotech devices, by Application USD Million (2015-2020)
  • Table 94. United Kingdom Neurotech devices, by Disease USD Million (2015-2020)
  • Table 95. United Kingdom Neurotech devices, by End Use USD Million (2015-2020)
  • Table 96. Netherlands Neurotech devices, by Type USD Million (2015-2020)
  • Table 97. Netherlands Neurotech devices, by Application USD Million (2015-2020)
  • Table 98. Netherlands Neurotech devices, by Disease USD Million (2015-2020)
  • Table 99. Netherlands Neurotech devices, by End Use USD Million (2015-2020)
  • Table 100. Rest of Europe Neurotech devices, by Type USD Million (2015-2020)
  • Table 101. Rest of Europe Neurotech devices, by Application USD Million (2015-2020)
  • Table 102. Rest of Europe Neurotech devices, by Disease USD Million (2015-2020)
  • Table 103. Rest of Europe Neurotech devices, by End Use USD Million (2015-2020)
  • Table 104. MEA Neurotech devices, by Country USD Million (2015-2020)
  • Table 105. MEA Neurotech devices, by Type USD Million (2015-2020)
  • Table 106. MEA Neurotech devices, by Application USD Million (2015-2020)
  • Table 107. MEA Neurotech devices, by Disease USD Million (2015-2020)
  • Table 108. MEA Neurotech devices, by End Use USD Million (2015-2020)
  • Table 109. Middle East Neurotech devices, by Type USD Million (2015-2020)
  • Table 110. Middle East Neurotech devices, by Application USD Million (2015-2020)
  • Table 111. Middle East Neurotech devices, by Disease USD Million (2015-2020)
  • Table 112. Middle East Neurotech devices, by End Use USD Million (2015-2020)
  • Table 113. Africa Neurotech devices, by Type USD Million (2015-2020)
  • Table 114. Africa Neurotech devices, by Application USD Million (2015-2020)
  • Table 115. Africa Neurotech devices, by Disease USD Million (2015-2020)
  • Table 116. Africa Neurotech devices, by End Use USD Million (2015-2020)
  • Table 117. North America Neurotech devices, by Country USD Million (2015-2020)
  • Table 118. North America Neurotech devices, by Type USD Million (2015-2020)
  • Table 119. North America Neurotech devices, by Application USD Million (2015-2020)
  • Table 120. North America Neurotech devices, by Disease USD Million (2015-2020)
  • Table 121. North America Neurotech devices, by End Use USD Million (2015-2020)
  • Table 122. United States Neurotech devices, by Type USD Million (2015-2020)
  • Table 123. United States Neurotech devices, by Application USD Million (2015-2020)
  • Table 124. United States Neurotech devices, by Disease USD Million (2015-2020)
  • Table 125. United States Neurotech devices, by End Use USD Million (2015-2020)
  • Table 126. Canada Neurotech devices, by Type USD Million (2015-2020)
  • Table 127. Canada Neurotech devices, by Application USD Million (2015-2020)
  • Table 128. Canada Neurotech devices, by Disease USD Million (2015-2020)
  • Table 129. Canada Neurotech devices, by End Use USD Million (2015-2020)
  • Table 130. Mexico Neurotech devices, by Type USD Million (2015-2020)
  • Table 131. Mexico Neurotech devices, by Application USD Million (2015-2020)
  • Table 132. Mexico Neurotech devices, by Disease USD Million (2015-2020)
  • Table 133. Mexico Neurotech devices, by End Use USD Million (2015-2020)
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Neurotech devices: by Type(USD Million)
  • Table 145. Neurotech devices Neuroprosthetics , by Region USD Million (2021-2026)
  • Table 146. Neurotech devices Neural stimulators , by Region USD Million (2021-2026)
  • Table 147. Neurotech devices Neurorehabilitation , by Region USD Million (2021-2026)
  • Table 148. Neurotech devices Neurosensing , by Region USD Million (2021-2026)
  • Table 149. Neurotech devices Others , by Region USD Million (2021-2026)
  • Table 150. Neurotech devices: by Application(USD Million)
  • Table 151. Neurotech devices Hospitals , by Region USD Million (2021-2026)
  • Table 152. Neurotech devices Clinics , by Region USD Million (2021-2026)
  • Table 153. Neurotech devices Diagnostic Centers , by Region USD Million (2021-2026)
  • Table 154. Neurotech devices: by Disease(USD Million)
  • Table 155. Neurotech devices Parkinson's Disease , by Region USD Million (2021-2026)
  • Table 156. Neurotech devices Cerebral Palsy , by Region USD Million (2021-2026)
  • Table 157. Neurotech devices Cognitive Disorders , by Region USD Million (2021-2026)
  • Table 158. Neurotech devices Epilepsy, Incontinence , by Region USD Million (2021-2026)
  • Table 159. Neurotech devices Migraine , by Region USD Million (2021-2026)
  • Table 160. Neurotech devices Hearing Conditions , by Region USD Million (2021-2026)
  • Table 161. Neurotech devices Chronic Pain , by Region USD Million (2021-2026)
  • Table 162. Neurotech devices Spinal Cord Injury , by Region USD Million (2021-2026)
  • Table 163. Neurotech devices Stroke , by Region USD Million (2021-2026)
  • Table 164. Neurotech devices Traumatic Brain Injury , by Region USD Million (2021-2026)
  • Table 165. Neurotech devices: by End Use(USD Million)
  • Table 166. Neurotech devices Diagnostics , by Region USD Million (2021-2026)
  • Table 167. Neurotech devices Therapeutics , by Region USD Million (2021-2026)
  • Table 168. South America Neurotech devices, by Country USD Million (2021-2026)
  • Table 169. South America Neurotech devices, by Type USD Million (2021-2026)
  • Table 170. South America Neurotech devices, by Application USD Million (2021-2026)
  • Table 171. South America Neurotech devices, by Disease USD Million (2021-2026)
  • Table 172. South America Neurotech devices, by End Use USD Million (2021-2026)
  • Table 173. Brazil Neurotech devices, by Type USD Million (2021-2026)
  • Table 174. Brazil Neurotech devices, by Application USD Million (2021-2026)
  • Table 175. Brazil Neurotech devices, by Disease USD Million (2021-2026)
  • Table 176. Brazil Neurotech devices, by End Use USD Million (2021-2026)
  • Table 177. Argentina Neurotech devices, by Type USD Million (2021-2026)
  • Table 178. Argentina Neurotech devices, by Application USD Million (2021-2026)
  • Table 179. Argentina Neurotech devices, by Disease USD Million (2021-2026)
  • Table 180. Argentina Neurotech devices, by End Use USD Million (2021-2026)
  • Table 181. Rest of South America Neurotech devices, by Type USD Million (2021-2026)
  • Table 182. Rest of South America Neurotech devices, by Application USD Million (2021-2026)
  • Table 183. Rest of South America Neurotech devices, by Disease USD Million (2021-2026)
  • Table 184. Rest of South America Neurotech devices, by End Use USD Million (2021-2026)
  • Table 185. Asia Pacific Neurotech devices, by Country USD Million (2021-2026)
  • Table 186. Asia Pacific Neurotech devices, by Type USD Million (2021-2026)
  • Table 187. Asia Pacific Neurotech devices, by Application USD Million (2021-2026)
  • Table 188. Asia Pacific Neurotech devices, by Disease USD Million (2021-2026)
  • Table 189. Asia Pacific Neurotech devices, by End Use USD Million (2021-2026)
  • Table 190. China Neurotech devices, by Type USD Million (2021-2026)
  • Table 191. China Neurotech devices, by Application USD Million (2021-2026)
  • Table 192. China Neurotech devices, by Disease USD Million (2021-2026)
  • Table 193. China Neurotech devices, by End Use USD Million (2021-2026)
  • Table 194. Japan Neurotech devices, by Type USD Million (2021-2026)
  • Table 195. Japan Neurotech devices, by Application USD Million (2021-2026)
  • Table 196. Japan Neurotech devices, by Disease USD Million (2021-2026)
  • Table 197. Japan Neurotech devices, by End Use USD Million (2021-2026)
  • Table 198. India Neurotech devices, by Type USD Million (2021-2026)
  • Table 199. India Neurotech devices, by Application USD Million (2021-2026)
  • Table 200. India Neurotech devices, by Disease USD Million (2021-2026)
  • Table 201. India Neurotech devices, by End Use USD Million (2021-2026)
  • Table 202. South Korea Neurotech devices, by Type USD Million (2021-2026)
  • Table 203. South Korea Neurotech devices, by Application USD Million (2021-2026)
  • Table 204. South Korea Neurotech devices, by Disease USD Million (2021-2026)
  • Table 205. South Korea Neurotech devices, by End Use USD Million (2021-2026)
  • Table 206. Taiwan Neurotech devices, by Type USD Million (2021-2026)
  • Table 207. Taiwan Neurotech devices, by Application USD Million (2021-2026)
  • Table 208. Taiwan Neurotech devices, by Disease USD Million (2021-2026)
  • Table 209. Taiwan Neurotech devices, by End Use USD Million (2021-2026)
  • Table 210. Australia Neurotech devices, by Type USD Million (2021-2026)
  • Table 211. Australia Neurotech devices, by Application USD Million (2021-2026)
  • Table 212. Australia Neurotech devices, by Disease USD Million (2021-2026)
  • Table 213. Australia Neurotech devices, by End Use USD Million (2021-2026)
  • Table 214. Rest of Asia-Pacific Neurotech devices, by Type USD Million (2021-2026)
  • Table 215. Rest of Asia-Pacific Neurotech devices, by Application USD Million (2021-2026)
  • Table 216. Rest of Asia-Pacific Neurotech devices, by Disease USD Million (2021-2026)
  • Table 217. Rest of Asia-Pacific Neurotech devices, by End Use USD Million (2021-2026)
  • Table 218. Europe Neurotech devices, by Country USD Million (2021-2026)
  • Table 219. Europe Neurotech devices, by Type USD Million (2021-2026)
  • Table 220. Europe Neurotech devices, by Application USD Million (2021-2026)
  • Table 221. Europe Neurotech devices, by Disease USD Million (2021-2026)
  • Table 222. Europe Neurotech devices, by End Use USD Million (2021-2026)
  • Table 223. Germany Neurotech devices, by Type USD Million (2021-2026)
  • Table 224. Germany Neurotech devices, by Application USD Million (2021-2026)
  • Table 225. Germany Neurotech devices, by Disease USD Million (2021-2026)
  • Table 226. Germany Neurotech devices, by End Use USD Million (2021-2026)
  • Table 227. France Neurotech devices, by Type USD Million (2021-2026)
  • Table 228. France Neurotech devices, by Application USD Million (2021-2026)
  • Table 229. France Neurotech devices, by Disease USD Million (2021-2026)
  • Table 230. France Neurotech devices, by End Use USD Million (2021-2026)
  • Table 231. Italy Neurotech devices, by Type USD Million (2021-2026)
  • Table 232. Italy Neurotech devices, by Application USD Million (2021-2026)
  • Table 233. Italy Neurotech devices, by Disease USD Million (2021-2026)
  • Table 234. Italy Neurotech devices, by End Use USD Million (2021-2026)
  • Table 235. United Kingdom Neurotech devices, by Type USD Million (2021-2026)
  • Table 236. United Kingdom Neurotech devices, by Application USD Million (2021-2026)
  • Table 237. United Kingdom Neurotech devices, by Disease USD Million (2021-2026)
  • Table 238. United Kingdom Neurotech devices, by End Use USD Million (2021-2026)
  • Table 239. Netherlands Neurotech devices, by Type USD Million (2021-2026)
  • Table 240. Netherlands Neurotech devices, by Application USD Million (2021-2026)
  • Table 241. Netherlands Neurotech devices, by Disease USD Million (2021-2026)
  • Table 242. Netherlands Neurotech devices, by End Use USD Million (2021-2026)
  • Table 243. Rest of Europe Neurotech devices, by Type USD Million (2021-2026)
  • Table 244. Rest of Europe Neurotech devices, by Application USD Million (2021-2026)
  • Table 245. Rest of Europe Neurotech devices, by Disease USD Million (2021-2026)
  • Table 246. Rest of Europe Neurotech devices, by End Use USD Million (2021-2026)
  • Table 247. MEA Neurotech devices, by Country USD Million (2021-2026)
  • Table 248. MEA Neurotech devices, by Type USD Million (2021-2026)
  • Table 249. MEA Neurotech devices, by Application USD Million (2021-2026)
  • Table 250. MEA Neurotech devices, by Disease USD Million (2021-2026)
  • Table 251. MEA Neurotech devices, by End Use USD Million (2021-2026)
  • Table 252. Middle East Neurotech devices, by Type USD Million (2021-2026)
  • Table 253. Middle East Neurotech devices, by Application USD Million (2021-2026)
  • Table 254. Middle East Neurotech devices, by Disease USD Million (2021-2026)
  • Table 255. Middle East Neurotech devices, by End Use USD Million (2021-2026)
  • Table 256. Africa Neurotech devices, by Type USD Million (2021-2026)
  • Table 257. Africa Neurotech devices, by Application USD Million (2021-2026)
  • Table 258. Africa Neurotech devices, by Disease USD Million (2021-2026)
  • Table 259. Africa Neurotech devices, by End Use USD Million (2021-2026)
  • Table 260. North America Neurotech devices, by Country USD Million (2021-2026)
  • Table 261. North America Neurotech devices, by Type USD Million (2021-2026)
  • Table 262. North America Neurotech devices, by Application USD Million (2021-2026)
  • Table 263. North America Neurotech devices, by Disease USD Million (2021-2026)
  • Table 264. North America Neurotech devices, by End Use USD Million (2021-2026)
  • Table 265. United States Neurotech devices, by Type USD Million (2021-2026)
  • Table 266. United States Neurotech devices, by Application USD Million (2021-2026)
  • Table 267. United States Neurotech devices, by Disease USD Million (2021-2026)
  • Table 268. United States Neurotech devices, by End Use USD Million (2021-2026)
  • Table 269. Canada Neurotech devices, by Type USD Million (2021-2026)
  • Table 270. Canada Neurotech devices, by Application USD Million (2021-2026)
  • Table 271. Canada Neurotech devices, by Disease USD Million (2021-2026)
  • Table 272. Canada Neurotech devices, by End Use USD Million (2021-2026)
  • Table 273. Mexico Neurotech devices, by Type USD Million (2021-2026)
  • Table 274. Mexico Neurotech devices, by Application USD Million (2021-2026)
  • Table 275. Mexico Neurotech devices, by Disease USD Million (2021-2026)
  • Table 276. Mexico Neurotech devices, by End Use USD Million (2021-2026)
  • Table 277. Research Programs/Design for This Report
  • Table 278. Key Data Information from Secondary Sources
  • Table 279. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Neurotech devices: by Type USD Million (2015-2020)
  • Figure 5. Global Neurotech devices: by Application USD Million (2015-2020)
  • Figure 6. Global Neurotech devices: by Disease USD Million (2015-2020)
  • Figure 7. Global Neurotech devices: by End Use USD Million (2015-2020)
  • Figure 8. South America Neurotech devices Share (%), by Country
  • Figure 9. Asia Pacific Neurotech devices Share (%), by Country
  • Figure 10. Europe Neurotech devices Share (%), by Country
  • Figure 11. MEA Neurotech devices Share (%), by Country
  • Figure 12. North America Neurotech devices Share (%), by Country
  • Figure 13. Global Neurotech devices share by Players 2020 (%)
  • Figure 14. Global Neurotech devices share by Players (Top 3) 2020(%)
  • Figure 15. Global Neurotech devices share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 18. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 19. Advanced Bionics Corp (United States) Revenue, Net Income and Gross profit
  • Figure 20. Advanced Bionics Corp (United States) Revenue: by Geography 2020
  • Figure 21. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. Stryker Corporation (United States) Revenue: by Geography 2020
  • Figure 23. Axonics Modulation Technologies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Axonics Modulation Technologies Inc. (United States) Revenue: by Geography 2020
  • Figure 25. Boston Scientific Corp (United States) Revenue, Net Income and Gross profit
  • Figure 26. Boston Scientific Corp (United States) Revenue: by Geography 2020
  • Figure 27. Cogentix Medical (United States) Revenue, Net Income and Gross profit
  • Figure 28. Cogentix Medical (United States) Revenue: by Geography 2020
  • Figure 29. Cleveland Medical Devices (United States) Revenue, Net Income and Gross profit
  • Figure 30. Cleveland Medical Devices (United States) Revenue: by Geography 2020
  • Figure 31. LivaNova (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. LivaNova (United Kingdom) Revenue: by Geography 2020
  • Figure 33. Medtronic (United States) Revenue, Net Income and Gross profit
  • Figure 34. Medtronic (United States) Revenue: by Geography 2020
  • Figure 35. Natus Medical Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 36. Natus Medical Incorporated (United States) Revenue: by Geography 2020
  • Figure 37. Global Neurotech devices: by Type USD Million (2021-2026)
  • Figure 38. Global Neurotech devices: by Application USD Million (2021-2026)
  • Figure 39. Global Neurotech devices: by Disease USD Million (2021-2026)
  • Figure 40. Global Neurotech devices: by End Use USD Million (2021-2026)
  • Figure 41. South America Neurotech devices Share (%), by Country
  • Figure 42. Asia Pacific Neurotech devices Share (%), by Country
  • Figure 43. Europe Neurotech devices Share (%), by Country
  • Figure 44. MEA Neurotech devices Share (%), by Country
  • Figure 45. North America Neurotech devices Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Advanced Bionics Corp (United States)
  • Stryker Corporation (United States)
  • Axonics Modulation Technologies Inc. (United States)
  • Boston Scientific Corp (United States)
  • Cogentix Medical (United States)
  • Cleveland Medical Devices (United States)
  • LivaNova (United Kingdom)
  • Medtronic (United States)
  • Natus Medical Incorporated (United States)
Additional players considered in the study are as follows:
Neuronetics (United States) , EndoStim Inc. (United States) , Flow Neuroscience AB (Sweden) , NeuroSigma (United States) , Restorative Therapies Inc. (United States) , Zynex Medical Inc. (United States)
Select User Access Type

Key Highlights of Report


Apr 2021 229 Pages 73 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Neurotech devices Market Quantitative research analysis
Global Neurotech devices Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Neurotech devices Market Report?

Have a Query? Click Here

Other Related Reports

Conduction Vaporizers Comprehensive Study by Type (Portable, Desktop), Distribution Channel (Online, Offline), Consumer Material (Dry Herb, Wax, Oil, Others) Players and Region - Global Market Outloo...
$ 3500
Electric Pads Comprehensive Study by Type (Regular Heating Pads, Neck and Shoulder Heating Pad, Portable Heating Pads), Application (Hospitals, Clinics, Residential Use), Distribution Channel (Onlin...
$ 3750
Disposable Oral Care Devices Comprehensive Study by Type (Oral Care Kits, Ventilator Kits, Oral Swabs, Suction Swab Kits, Suction Catheters), Application (Hospitals, Nursing homes, Specialty clinics,...
$ 3350
Corneal Topographer Comprehensive Study by Type (Placido Disc System, Scheimpflug System, Scanning Slit System), Application (Refractive Surgery Evaluation, Cataract Surgery Evaluation, Corneal Disor...
$ 3650
Next Generation Pipettes Comprehensive Study by Type (Automatic, Semiautomatic, Manual), Application (Biological Field, Chemical Field, Medical Field), Distribution Channel (Online, Offline), End-Use...
$ 3450
Temperature Capsule Comprehensive Study by Application (Healthcare/Medical, Sport & Fitness, Other), Components (Sensor, Data recorder, Software), Distribution Channel (Online, Offline) Players and R...
$ 3500